Exchange: NASDAQ·Updated 07:57 PM EDT
CRSP logo

CRSP CRISPR Therapeutics AG

$53.39
$2.95
(5.85%)
Today
Closed $53.39
$0.30
(0.56%)
After Hours
EarningsNov 9
Mkt Cap$4.88B
Vol1.47M

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
66

Bullish Sentiment

How do you feel about CRSP?

2bull2furious
$CRSP God give me $3250 a share and I swear i'll sell out and never buy another stock for the rest of my days
19
TannerTDB
$CRSP Stock is way undervalued, way over shorted for years and people are buying finally due to the Plauge in Russia... Can't make this shit up, here for the short squeeze though.
11
burbs88
$CRSP Not mentioned in the catalysts posted below, is the potential for a major partnership. This could literally happen at any time and could send the stock to 100+ in a heartbeat if they land a major partner for CTX310. There is a decent chance of a partnership right now, however, with positive phase 1b data the likelihood of a partnership becomes practically certain. The numbers associated with this particular drug and partnership, would likely dwarf those of Casgevy and the market would be forced to take notice. The day to day, short term movement of this stock should really be irrelevant to long term investors. The company is very close to justifying a much higher market cap. Follow the details, not the manipulated day to day movement of the stock.
1
9
ShyGuy82433
$CRSP potential timing on remaining catalysts for the remainder of the year (per CHATGPT)
12
DinoGT
$CRSP data from the abstract is a banger! Very promising early zugo data.. on par with autologous car-T efficacy. A positive Nov8th durability / efficacy / safety update would be huge for the zugo thesis. Early days.. but all signs pointing in the right direction!
10
scottystonkz
$CRSP I'm also invested in cyber security and around a year ago Anthropic started spouting the same shit about how they will change cyber forever and developed all these products, caused cyber to to severely drop for months and months as institutions suspiciously increased positions in names like Rubrik. Obviously it all turned out to be a load of nonsense and cyber became even more important than ever sending the stocks back to aths up 50-60%. Looks like a repeat of that potentially...
10
ShyGuy82433
$CRSP Love this PR stunt by anthropic and love it even more than people are calling BS on Twitter. The timing of it all is comical 😂🫩nothing burger for CRSP
10
oneman_wolfpack
$CRSP Oct–Dec CTX310 Phase 1b Nov. 8 Zugo-cel – systemic sclerosis 2H 2026 Zugo-cel – SLE / rheumatology 2H 2026 Zugo-cel – ITP / wAIHA 2H 2026 Zugo-cel – oncology 2H 2026 CTX611 2026 CTX321 / Lp(a) 2H 2026 In-vivo HSC editing Quarterly CASGEVY I've been adding, won't stay down for much longer.
9
burbs88
$CRSP Holding this stock for five years must feel like getting waterboarded. I've held for almost a year now and it's been torture by repetition. However, this was not completely unexpected and I still feel confident long term. But lets be honest here, it's been a tremendously annoying hold. It drops just before it makes sense to trim and it rises just before it makes sense to buy more. Such an annoying stock. I'm fine with the company but this stock has been an intolerable shit show.
8
tgamble3
$CRSP probably some of the highest potential in the entire market and the 5 year chart looks like a barcode.
8
burbs88
$CRSP Just STFU and hold the stock for at least 5 years. Lol. It's a no brainer long term juggernaut company. Add on dips when you can. A lot of folks were way too early here and have soured on the company for illegitimate reasons...but they are still holding for a reason. For me, this is now a long term investment. They are close enough to profitability now to hold after spikes. I sold multiple times in 70's only to accumulate more on dips previously. There wiĺl still be plenty who swing trade this but to me, at this stage, this is an unbelievable opportunity to just sit on shares for 10 years. It's really simple. No need to try to be "Smart" with this ticker anymore.
8
ShyGuy82433
$CRSP literally this.. I’ll get excited once we see 70+ and never see 40s and 50s again lol
8
market_timer
$CRSP lolol don’t bother asking why the drop, its literally just automatic at $60. This is like the 15th time
7
Olddrache
$CRSP waiting for 48-9. Already 3+ round trips. Buy sub 49 , scale out 60-2. Rinse and repeat. Maybe one of these days, it actually breaks out.
2
1
JasonCO50BPS
$CRSP this one got done dirty. premarket pumper to absolute meltdown. watching low $40’s for a trade
6
RideTheBu77
$CRSP lmao ... this is even more fun than normal eh? We're just doing 8 point swings over morning brunch now? On no news?
6
The_Flying_Janitor
$CRSP Moved 1/2 of the entire range it’s been stuck in for a year in 1hr on no news and low volume 🤔… yah that seems fine, totally ok. Everyone just drink their coffee, look at your morning TicTocks, go buy your $6 a gallon gas on the way to your underpaid job. Ooh and make sure you put 6% of your crappy salary in your 401k like a good little boy or girl…. Wouldn’t want anybody to steal it from ya.
6
svertical1
$CRSP The Day is near where Shorts realize Cathy is right! Big effort to suppress price given 68.4% Short Volume.
5
ETFdb
$CRSP traders have an unexpected name to watch: Anthropic. 👀 The Claude maker’s reported discovery of a CRISPR-like enzyme system has traders debating potential competition in gene editing. The headline has put CRISPR Therapeutics in focus. That conversation reaches ETF portfolios, too. These four funds hold $CRSP, with allocations ranging from roughly 2% to 5%: 🧬 $ARKG: 5.20% $GNOM: 2.70% $SAMT: 2.49% $HTEC: 1.81%
1
2
QuietTrader
$CRSP - One of the more interesting oversold biotech setups right now. CRSP is testing key support around **$50**, with RSI approaching oversold territory and Stochastics deeply oversold. The MACD remains bearish, but a momentum reversal could trigger a sharp rebound. I'm watching **$52.50 → $55 → $57.50–$60** as potential recovery targets. The November 9 CTX310 Phase 1b clinical data presentation adds a major catalyst. A pre-data rally could develop as investors position ahead of the results. If Phase 1b validates that a one-time intravenous infusion provides permanent, safe lipid reduction in sHTG patients, it will solidify CRISPR's transition from ex vivo hematology into the massive, mainstream in vivo cardiovascular drug market. It looks like she wants to bounce off that 50ish support area.
4

Advertisement|Remove ads.